Staging can be complex and may vary depending on the type of cancer. Some cancers have their unique staging systems, like the Ann Arbor staging system for lymphoma or the FIGO system for gynecologic cancers. Additionally, new diagnostic technologies and biomarkers are continually evolving, leading to changes and updates in staging criteria.
